Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
92,935,152
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
2,239,166
-
Shares change
-
+962,811
-
Total reported value, excl. options
-
$3,582,021
-
Value change
-
+$1,631,639
-
Number of buys
-
10
-
Number of sells
-
-6
-
Price
-
$1.6
Significant Holders of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) as of Q2 2023
26 filings reported holding CNTX - Context Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q2 2023.
Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,239,166 shares
of 92,935,152 outstanding shares and own 2.41% of the company stock.
Largest 10 shareholders include Ally Bridge Group (NY) LLC (653,396 shares), VANGUARD GROUP INC (574,700 shares), Affinity Asset Advisors, LLC (267,574 shares), HighTower Advisors, LLC (125,852 shares), GEODE CAPITAL MANAGEMENT, LLC (107,234 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (105,809 shares), Mill Creek Capital Advisors, LLC (104,631 shares), UBS OCONNOR LLC (65,628 shares), NORTHERN TRUST CORP (37,219 shares), and Clear Harbor Asset Management, LLC (36,000 shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.